Hipro(Shenzhen)Biotechnology Co.,Ltd. established, with Hipro(Taizhou) in China Medical City became the wings of Hipro HQ.
Sep. of 2019, Hipro(Nanjing)Research Institute established, focus on the research about the reagents and the optical sensor.
May of 2018,the wholly-owned subsidiary of Hipro Biotechnology GMBH established in Freiburg,Germany ,for R&D center of Micro-fluidics Products, and Marketing in EU.
Feb. of 2017, Hipro’s products attended the Arab Health 2017 in Dubai.
In April, Hipro lauched the international market start from India. In October, the Mumbai office was established.
In May, the AAV laboratory was completed.
In July, Hipro and Shanghai Fosun joined forces to develop strategic cooperation on blood drug concentration projects.
Oct of 2016, Hipro purchased 3.67 hectares in Taizhou China Medical City , started the foundation for the Jiangsu branch.
Sep. of 2015, Hipro Biotech Guangzhou Marketing Center established.
Nov. of 2014 , Hipro passed the inspection of Quantum dot fluorescence test project , for pneumology.
May of 2013, 1000 ㎡ new factory opened in Fangyi tech-park.
In September, registered capital increased to RMB 20 millions.
May of 2013, Hipro’s corporate capital increased to RMB 20 millions.
May of 2012, Hipro’s corporate capital increased to RMB 5 millions.
Hipro’s corporate capital increased to RMB 11 millions.
First time, Hipro’s products attended the international exhibition - AACC USA.
Mar.of 2011, Hipro completed the share restructuring and absorbed the government fund of Hebei Science and Technology Department to participate in the BOOT form.
May of 2010, Hipro’s corporate capital increased to RMB 5 millions.
Aug.of 2009, Hipro merged Huayang Analytical Instrument Co., Ltd., Which has 10 years experience in chemiluminescence immunoassay equipment manufactural area.
Jan. of 2008 , Hipro cooperated with RADIM SEAC of Italy to research on scattering turbidity technology.
Feb.of 2008, Hipro cooperated with Hygiena (USA) Corporation to produce ATP testing equipment for food security.
June of 2007, Hipro cooperate with Cypress(USA), set up china base to produce diagnostic reagents & instruments.
June of 2007, Hipro’s corporate capital increased to RMB 1 millions.
Sep. of 2006, Hipro established, registered capital in RMB 30,000.00.